| SFDA Approved Use |
Glycerol Phenylbutyrate is indicated for use as adjunctive therapy for chronic management of patients with urea cycle disorders (UCDs)including deficiencies of carbamoyl phosphate synthetase I (CPS), ornithine carbamoyltransferase (OTC),argininosuccinate synthetase (ASS), argininosuccinate lyase (ASL), arginase I (ARG) and ornithine translocasedeficiency hyperornithinaemia-hyperammonaemia homocitrullinuria syndrome (HHH) who cannot be managed by dietaryprotein restriction and/or amino acid supplementation alone. |
|---|
An official government website affiliated with the Government of the Kingdom of Saudi Arabia.
Beta version
Official Saudi government website domains end with gov.sa
All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.
Official Reliable websites use HTTPS
Ensure the website is using the HTTPS protocol.
Registered with the Digital Government Authority under number:
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.